Background: Presently due to technological advances, operative laparoscopy now plays a crucial role in the management of pelvic malignancies. With newly developed techniques to complete both pelvic and para-aortic lymph node dissection, the use of the laparoscope has increased in patients with pelvic malignancies. Gynecological oncologists are currently incorporating the techniques of operative laparoscopy in the management of patients with cervical, endometrial, and ovarian cancer.
INTRODUCTION
In the past, the laparoscope has been used for few procedures like diagnostic and sterilization procedures. Due to technologic advances, operative laparoscopy and other minimal invasive surgical techniques now play a important role in the management of a wide variety of benign gynecological conditions including ectopic pregnancy,
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endometriosis, pelvic pain, leiomyomata and adnexal masses. Similarly, the role of minimal invasive surgery in the management of malignant disease has expanded. With newly developed techniques to complete both pelvic and para-aortic lymph node dissection, the use of minimal invasive surgical techniques has increased in patients with pelvic malignancies. Gynecologic oncologists are currently incorporating the techniques of minimal invasive surgery in the management of patients with cervical, endometrial and ovarian cancer.
Radical vaginal trachelectomy with laparoscopic pelvic lymphadenectomy has emerged as a safe, reasonable option for women with early-stage cervical cancer desiring fertility preservation. Similarly, laparoscopic radical hysterectomy with pelvic lymphadenectomy has been systematically described, is feasible, and can be offered to women with early-stage cervical cancer who do not desire future childbearing. In the treatment of early stage endometrial cancer, the surgical approach of laparoscopic hysterectomy, peritoneal washings, and pelvic and para-aortic lymph node dissection, with or without an omentectomy, is being compared with the same surgery performed via laparotomy in the cooperative gynecologic oncology group (GOG) LAP 2 study, which has completed accrual, and appears to be a reasonable surgical option. In ovarian cancer, minimally invasive surgery has been incorporated to manage early-stage, advanced-stage, and recurrent disease, as well as second-look procedures. Hand-assisted laparoscopy has also recently been described in managing larger volume primary and recurrent gynecologic cancers.
AIMS AND OBJECTIVES
To review literature on the role of minimal invasive surgery in various gynecological cancers.
MATERIALS AND METHODS
An extensive literature search online was done through PubMed, Wikipedia, Cochrane and videos via YouTube.
REVIEW OF ART ICLES

Cervical Cancer
The issue of laparoscopy in the management of locally advanced cervical cancer has been addressed by several authors. In particular, researchers from Korea, Chung et al, 1 
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evaluated the feasibility and safety of pretreatment laparoscopic surgical staging in the treatment of locally advanced cervical cancer. The authors contended that pretreatment laparoscopy is the best guideline for individualized concurrent chemoradiation. When compared with magnetic resonance imaging, laparoscopic surgical staging was superior in detecting microscopic lymph node metastases.
Various studies summarized in Tables 1 to 3 respectively at various places.
Thus, while abdominal radical hysterectomy remains the standard of care for early-stage cervical cancer, laparoscopic radical hysterectomy appears to be a safe, reasonable alternative. Operative laparoscopy has also been used as a means of determining a patient's eligibility for pelvic exenteration for recurrent cervical cancer, removal of diseased adnexae, and ovarian transposition. It has been proven to be a valuable step in the workup and management of patients with locally recurrent cervical cancer.
Endometrial Cancer
Operative laparoscopy is also useful in the management of patients with malignancies of the uterine corpus. In 1988, endometrial cancer became a surgically staged malignancy according to FIGO. The importance of pelvic and para-aortic lymph node status documented by a large GOG study was instrumental in motivating the change to surgical staging.
Various studies are summarized in Table 2 : Patients managed with a laparoscopic approach had the same number of lymph nodes removed, but had less complications, a shorter hospital stay and quicker recovery than the laparotomy group. In addition to surgical staging in the primary management of endometrial carcinoma patients, the technique can be utilized in patients with incomplete staging of disease at their primary surgery.
Ovarian Cancers
Epithelial ovarian cancer is one of the leading causes of death in gynecological malignancies and the seventh most common cancer in the world among women. Minimally invasive surgery for patients with ovarian cancer can be incorporated in different ways depending on the stage of disease and surgical goals of the procedure. In advanced stage disease, laparoscopy in general can be used to confirm diagnosis and determine resectability. In early-stage disease, patients can be comprehensively staged via the laparoscopic approach. The laparoscopic Not available The laparoscopic approach for radical hysterectomy was safe, feasible, and associated with low morbidity. The median operative time was longer for the laparoscopic approach, while the hospital stay and EBL were significantly less in the laparoscopic group. 4 Marnitz et al 5 Prospective
Patients with locally advanced cervical cancer who were selected for laparoscopic staging for primary chemoradiation.
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They found that removal of more than five pelvic and/or more than five para-aortic lymph nodes was associated with signifi cantly longer overall survival. The authors concluded that debulking of tumor-involved lymph nodes should be performed prior to primary chemoradiation in patients with locally advanced cervical cancer. 5 Kohler et al 6 Prospective Patients undergoing explorative laparoscopy to determine eligibility for exenteration 41 Almost half (48.7%) of the patients avoided unnecessary exenteration for unresectable disease or intra-abdominal spread of disease.
second-look procedure is a reasonable approach to assessing disease status at completion of adjuvant chemotherapy in selected patients. Various studies are summarized in Table 3 . The rates of negative evaluations and recurrence rates were comparable between patients undergoing laparoscopy and those undergoing laparotomy for ovarian cancers.
DISCUSSION
It is clear that minimally invasive surgery approaches to the management of gynecologic malignancies are feasible and provide exciting alternatives. Operating times intuitively have improved with greater surgical experience. In addition, adequacy of the procedure being performed needs to be assured. Comparison of recurrence rates and survival provide some insight. Schlaerth et al 16 evaluated women with cervical cancer undergoing laparoscopic retroperitoneal lymphadenectomy followed-by imme-diate laparotomy to assess the adequacy of lymph node removal. In that study, the investigators reported that laparoscopic aortic lymph node sampling could be performed safely and adequately. Laparoscopic pelvic lymphadenectomy was noted at the time of laparotomy to have residual tissue lateral to the common iliac vessel and distal external iliac vessels in 15% of patients. Because none of the laparoscopic surgeons were aware of the pre- highlight the difficulties of trocar placement in patients who are morbidly obese. Childers et al 20 also found that, in patients with endometrial cancer, obesity was the limiting factor in performing lymphadenectomies. Eltabbakh et al were unable to perform para-aortic lymph node samplings in two patients because of poor visualization secondary to obesity. However, they did report higher pelvic lymph node yields laparoscopically when compared with laparotomy. Finally, assessment of complications and conversion rate need to be addressed as the role of minimally invasive surgery increases in the management of gynecologic cancers. In evaluating their initial 10-year experience with laparoscopy, Chi et al 21 noted a low complication rate (2.5% grade 3-5) and a low conversion rate of 7%. They identified older age, malignancy, previous radiation, and previous abdominal surgery as significant risk factors for complications or conversion to laparotomy, which should help guide patient selection and surgical planning.
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CONCLUSION
After a literature search, it seems that minimal invasive surgical staging operation is a safe and effective therapeutic procedure for management of gynecological cancers, with an acceptable morbidity compared to the laparotomic approach, and is characterized by far less blood loss and shorter postoperative hospitalization time.
Recently, some reports demonstrated that robotic surgery is superior to laparoscopy in surgical staging of endometrial cancer. 22, 23 However, the high cost limits universal use. Further multicenter randomized trials with longer follow-up should be necessary to evaluate the overall oncologic outcomes of this procedure.
